Skip to main content
. 2021 Sep 3;139(8):1198–1207. doi: 10.1182/blood.2021012775

Figure 2.

Figure 2

BAX mutations detected in the non-CLL compartment of patients on long-term venetoclax therapy for relapsed/refractory CLL. Location and type of variants are indicated by color-coded triangles on linear protein structure of BAX. Splice site variants are indicated below the protein at positions relative to their nucleotide position.